MabPlex

MabPlex provides end-to-end global CDMO services for biologics including mAbs, recombinant proteins, ADCs and bispecifics. The company has established itself as an industry leader in large-scale ADC manufacturing with state-of-the-art facilities meeting US/EU/China GMP standards. It enables rapid cell line development and scale-up using advanced single-use bioreactors and proprietary process controls that ensure high quality and consistency. Recognized by Frost & Sullivan for growth leadership in the ADC contract manufacturing sector. No direct clinical results since it operates as a service provider to pharma/biotech partners rather than developing its own drugs.